Notification of cessation of +securities
Announcement Summary
For personal seu only
Entity name
CRESO PHARMA LIMITED
Announcement Type
New announcement
Date of this announcement
Wednesday November 17, 2021
Details of +securities that have ceased
Number of | ||||
ASX +security | +securities that | The +securities have | Date of | |
code | Security description | have ceased | ceased due to | cessation |
CPHAAQ | OPTION EXPIRING | 200,000 | Cancellation by agreement | 09/11/2021 |
03-NOV-2024 EX $0.20 | between the entity and the | |||
holder |
Refer to next page for full details of the announcement
Notification of cessation of +securities | 1 / 6 |
Notification of cessation of +securities
Part 1 - Announcement Details
For personal use only
1.1 Name of +Entity
CRESO PHARMA LIMITED
We (the entity named above) provide the following information about our issued capital.
1.2 | Registered Number Type | Registration Number |
ABN | 89609406911 | |
1.3 | ASX issuer code | |
CPH |
- The announcement is New announcement
- Date of this announcement
17/11/2021
Notification of cessation of +securities | 2 / 6 |
Notification of cessation of +securities
Part 2 - Details of +equity securities or +debt securities that have ceased
For personal use only
ASX +Security Code and Description
CPHAAQ : OPTION EXPIRING 03-NOV-2024 EX $0.20
Unquoted +equity securities that have ceased
Number of securities that have ceased
200,000
Reason for cessation
Cancellation by agreement between the entity and the holder
Date of cessation | Is the entity paying any consideration for the cessation? |
9/11/2021 | No |
Any other information the entity wishes to notify to ASX about the cessation?
Refer to the ASX release dated 9 November 2021.
Notification of cessation of +securities | 3 / 6 |
Notification of cessation of +securities
For personal use only
Notification of cessation of +securities | 4 / 6 |
Notification of cessation of +securities
Part 3 - Issued capital following changes
For personal use only
Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:
3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)
Total number of | |
ASX +security code and description | +securities on issue |
CPHOA : OPTION EXPIRING 22-JAN-2023 | 66,648,930 |
CPH : ORDINARY FULLY PAID | 1,206,529,437 |
CPHO : OPTION EXPIRING 02-NOV-2024 | 400,942,239 |
3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)
Total number of | |
ASX +security code and description | +securities on issue |
CPHAAN : OPTION EXPIRING 06-SEP-2024 EX $0.25 | 10,000,000 |
CPHAAO : PERFORMANCE RIGHTS | 15,000,000 |
CPHAY : OPTION EXPIRING 02-JUN-2023 EX 17C | 27,764,706 |
CPHAAA : OPTION EXPIRING 02-JUN-2023 EX 20C | 8,000,000 |
CPHAZ : OPTION EXPIRING 02-JUN-2023 EX 25C | 4,000,000 |
CPHAQ : OPTION EXPIRING 15-SEP-2022 EX 80C | 300,000 |
CPHAAQ : OPTION EXPIRING 03-NOV-2024 EX $0.20 | 0 |
CPHAAB : OPTION EXPIRING 25-JUN-2023 EX 13.86C | 5,752,688 |
CPHAAL : OPTION EXPIRING 01-AUG-2024 EX $0.18 | 12,000,000 |
CPHAS : OPTION EXPIRING 12-FEB-2023 EX 40C | 6,847,725 |
CPHAT : OPTION EXPIRING 12-FEB-2023 EX 35C | 2,128,387 |
CPHAAK : OPTION EXPIRING 01-AUG-2024 EX $0.15 | 12,000,000 |
Notification of cessation of +securities | 5 / 6 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Creso Pharma Ltd. published this content on 17 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 November 2021 07:16:02 UTC.